Search Results - "Stock, Elyse G"

Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine by Lipton, Richard B, Croop, Robert, Stock, Elyse G, Stock, David A, Morris, Beth A, Frost, Marianne, Dubowchik, Gene M, Conway, Charles M, Coric, Vladimir, Goadsby, Peter J

“…Treatment with the oral calcitonin gene–related peptide receptor antagonist rimegepant resulted in freedom from migraine pain 2 hours after the dose in 20% of…”
Get full text

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder by Coric, Vladimir, Feldman, Howard H., Oren, Dan A., Shekhar, Anantha, Pultz, Joseph, Dockens, Randy C., Wu, Xiaoling, Gentile, Kimberly A., Huang, Shu-Pang, Emison, Eileen, Delmonte, Terrye, D'Souza, Bernadette B., Zimbroff, Daniel L., Grebb, Jack A., Goddard, Andrew W., Stock, Elyse G.

“…Background: Antagonism of corticotropin‐releasing factor (CRF) receptors has been hypothesized as a potential target for the development of novel anxiolytics…”
Get full text

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial by Croop, Robert, Lipton, Richard B, Kudrow, David, Stock, David A, Kamen, Lisa, Conway, Charles M, Stock, Elyse G, Coric, Vladimir, Goadsby, Peter J

“…Rimegepant is a calcitonin gene-related peptide receptor antagonist that has shown efficacy and safety in the acute treatment of migraine. We aimed to compare…”
Get full text

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial by Croop, Robert, Goadsby, Peter J, Stock, David A, Conway, Charles M, Forshaw, Micaela, Stock, Elyse G, Coric, Vladimir, Lipton, Richard B

“…Rimegepant, a small molecule calcitonin gene-related peptide receptor antagonist, has shown efficacy in the acute treatment of migraine using a standard tablet…”
Get full text

Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: A placebo-controlled 26-week study by PIGOTT, Teresa A, CARSON, William H, SAHA, Anutosh R, TORBEYNS, Anne F, STOCK, Elyse G, INGENITO, Gary G

“…Aripiprazole is a novel antipsychotic for the management of schizophrenia. This study investigated the efficacy, safety, and tolerability of aripiprazole in…”
Get full text

A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA) by Tandon, Rajiv, Marcus, Ronald N., Stock, Elyse G., Riera, Linda C., Kostic, Dusan, Pans, Miranda, McQuade, Robert D., Nyilas, Margaretta, Iwamoto, Taro, Crandall, David T.

“…BETA was designed to evaluate the overall effectiveness of aripiprazole in patients with schizophrenia or schizoaffective disorder treated in a general…”
Get full text

Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder by Coric, Vladimir, Stock, Elyse G, Pultz, Joseph, Marcus, Ronald, Sheehan, David V

“…Accurate and prospective assessments of treatment-emergent suicidal thoughts and behaviors are essential to both clinical care and randomized clinical trials…”
Get full text

Talc Granuloma Identified by X-ray Microanalysis by Terzakis, John A, Shustak, Sandra R, Stock, Elyse G

“…SOPHISTICATED analytical techniques now available may solve problems in the differential diagnosis of reactive and neoplastic diseases. An example is provided…”
Get full text